Cargando…
P04 A case of zoledronate-induced ANCA associated vasculitis
INTRODUCTION: Bisphosphonates are a well-established treatment for osteoporosis and other metabolic bone disorders. In up to 40% of recipients, infusion is associated with a transient cytokine-mediated acute-phase response. It has been hypothesised that this can rarely cause autoimmune reactions, wi...
Autores principales: | Biddle, Kathryn, Attipoe, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532181/ http://dx.doi.org/10.1093/rap/rkad070.025 |
Ejemplares similares
-
P20 Scleritis as initial presenting feature in ANCA-associated vasculitis
por: Peddasomayajula, Subrahmanyam, et al.
Publicado: (2021) -
PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
por: Mestrallet, G, et al.
Publicado: (2013) -
ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020) -
Altered innate functions of myeloid dendritic cells in ANCA-associated vasculitis
por: Braudeau, Cécile, et al.
Publicado: (2012) -
The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)